Cite

MLA Citation

    Manmeet Ahluwalia et al.. “ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma.” Neuro-oncology, vol. 20, n.d., pp. vi10–vi11. http://access.bl.uk/ark:/81055/vdc_100095509485.0x000019
  
Back to record